Insulin-sensitizing, blood pressure-lowering, and antiatherosclerotic properties of IGFBP-1 have been demonstrated, raising the possibility that increasing IGFBP-1 levels may be a therapeutic option to protect individuals from IR, arterial hypertension, and atherosclerosis [73]. The gene discussed is IGFBP1; the disease is atherosclerosis.